• PHP114 Review of Cost Effectiveness Studies of High Budget Impact Drugs (2007-2012)

    Nov 1, 2012, 00:00

  • PHP53 Comparative Evaluation of Drug Information Sources Used by Doctors

    Nov 1, 2012, 00:00

  • PCN128 Estimating the Value of Companion Diagnostics- Are the Incentives Right?

    Nov 1, 2012, 00:00

  • PHP112 Estimating the Probability of a Favorable Assessment of Clinical Benefits for a New Drug in Germany Using an MCDA Approach

    Nov 1, 2012, 00:00

  • PHS71 Health Related Quality of Life of HIV Patients at a Tertiary Care Hospital in Bangalore

    Nov 1, 2012, 00:00

  • PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of Chemotherapy

    Nov 1, 2012, 00:00

  • PRS30 Cost-Effectiveness Analysis of 100% Whey-Based Partially Hydrolyzed Infant Formula Used for Prevention of Atopic Dermatitis in Germany

    Nov 1, 2012, 00:00

  • CL1 A Novel Method for Calculating Prevalence of Multiple Sclerosis in Australia

    Nov 1, 2012, 00:00

  • PCV86 The Burden of Non-Adherent Prescription Cost Cutting Among Diagnosed Hypertension Patients in Russia

    Nov 1, 2012, 00:00

  • PMD62 Cost-Effectiveness in Diagnostic Tests- Comparison of the IBD Pre-Endoscopic Screening F-Calprotectin Test Versus Serologic Markers in Selected European Markets

    Nov 1, 2012, 00:00

  • PND21 Multiple Sclerosis in Russian Federation- Evaluation of Social and Economical Burden in Real Clinical Practice

    Nov 1, 2012, 00:00

  • PIN53 The Cost Effectiveness of Maternal and Infant Antiretroviral Regimens to Prevent Vertical Transmission in a Resource Poor Country

    Nov 1, 2012, 00:00

  • PMH24 Cost of Long-Acting Risperidone Injection Versus Long-Acting Paliperidone Palmitate in Patients With Schizophrenia in Russia

    Nov 1, 2012, 00:00

  • PDB16 Prospective and Retrospective Safety Review of Pioglitazone in a Medical Center

    Nov 1, 2012, 00:00

  • PCN84 Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer- An Economic Evaluation in the Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PMH16 Analysis of the Economic Burden and Cost Structure of Schizophrenia in Germany Using Observational Sickness Fund Data

    Nov 1, 2012, 00:00

  • PSU35 Epidemiological Modeling of Patient Survival After Heart Transplantation in Germany

    Nov 1, 2012, 00:00

  • PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia- An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients

    Nov 1, 2012, 00:00

  • PGI32 New Antiviral Drugs for Hepatitis C in Italy- Will it be a Treasure Hunt?

    Nov 1, 2012, 00:00

  • PHP11 Time Trends and Determinants of Pharmaceutical Expenditure in China in 1990-2009

    Nov 1, 2012, 00:00

  • PIH7 Immunization Providers' Cost and Vaccination Cost in Iraq

    Nov 1, 2012, 00:00

  • PMH2 Interim Results From the “AUTOR” Study, a European Observational Study in Pediatric Patients With Attention Deficit/Hyperactivity Disorder- Patient Characteristics and 1-Year Costs

    Nov 1, 2012, 00:00

  • CA2 Applying a Value-Based Price Across Different Disease Areas

    Nov 1, 2012, 00:00

  • PRM36 Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID)- Evolution of Content, Structure, and Functionalities (2002-2012)

    Nov 1, 2012, 00:00

  • PIN81 Perceptions of Hospital Pharmacists Regarding Effective Anti-Malarial Drug Management in Pakistan. A Qualitative Insight

    Nov 1, 2012, 00:00

  • PSU32 A Comparison of Resource Utilization and Medical Charges Among Lumbar Interbody Fusion Surgical Patients With and Without Revision

    Nov 1, 2012, 00:00

  • PHP22 Off-Label Use of Intravenous Non-Steroidal Anti-Inflammatory Drugs-Ketorolac in a Nationally Representative Population

    Nov 1, 2012, 00:00

  • PRM12 Evidence for Validity of a National Patient-Reported Survey in China- The China National Health and Wellness Survey

    Nov 1, 2012, 00:00

  • PIN90 Towards Best Practices for Handling Uncertainties in Health Technology Assessments for HPV Vaccination to Better Inform Decision Making

    Nov 1, 2012, 00:00

  • PDB18 Population Attributable Risk of Microvascular Events Associated With HbA1C, Blood Pressure or Weight in Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PHP145 Using an Evidence Database of Previous Nice HTA Decisions to Maximise Re-Review Strategy

    Nov 1, 2012, 00:00

  • PMS82 US Treatment Patterns in Psoriatic Arthritis Newly Initiated on Etanercept or Adalimumab

    Nov 1, 2012, 00:00

  • PRM146 An Excel Calculator Tool to Perform Meta-Analysis

    Nov 1, 2012, 00:00

  • PHS41 Cost Effectiveness Analysis of Two HIV Counseling and Testing Strategies in Kayunga District (Uganda)

    Nov 1, 2012, 00:00

  • PCN153 Application of Real World Data to Inform a Breast Cancer Decision - Analytic Model in Austria and the U.S - Preliminary Outcomes of Data Collection

    Nov 1, 2012, 00:00

  • PIN50 A Cost-Effectiveness Analysis of Telaprevir Versus Boceprevir in the Treatment of Hepatitis C- A Greek National Health System Perspective

    Nov 1, 2012, 00:00

  • PND15 Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) Compared to Benzodiazepines for the Treatment of Acute Prolonged Epileptic Seizures in Germany

    Nov 1, 2012, 00:00

  • PCV39 Cost Assessment of Drugs for Venous Thromboembolism Prevention After Hip or Knee Replacement in Mexican Population

    Nov 1, 2012, 00:00

  • PHP156 Amnog – Summary of Outcomes of Early Benefit Assessment and Reimbursement Negotiation for New Drugs in Germany

    Nov 1, 2012, 00:00

  • PCN67 Economic Evaluation of Mono and Sequential Hormone Therapies for ER+ Women With Early Breast Cancer in Canada

    Nov 1, 2012, 00:00

  • PRM147 Comparison of Indirect and Mixed Treatment Comparison (MTC) Meta-Analysis Techniques Used in the Evaluation of New Protease Inhibitors for the Treatment of Chronic Hepatitis C

    Nov 1, 2012, 00:00

  • PHP143 Exploratory Test of Stakeholder Theory in the Implementation Process of It-Innovations in Hospital Care

    Nov 1, 2012, 00:00

  • PMS44 Cost-Effectiveness of Alendronate Therapy Forcorticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in Japan

    Nov 1, 2012, 00:00

  • PSY7 Societal Burden Associated With Neuropathic Pain in Europe

    Nov 1, 2012, 00:00

  • PSS8 Non-Interventional Study on the Burden of Illness in Diabetic Macular Edema (DME) in Belgium

    Nov 1, 2012, 00:00

  • PMS57 Effect of Different Methods on Estimating Persistence to Oral Bisphosphonate Therapy in Portuguese PMO Patients – an Observational Prospective Study

    Nov 1, 2012, 00:00

  • PND6 Economic Burden of Structural-Metabolic Epilepsy in Malaysia

    Nov 1, 2012, 00:00

  • PRM89 Standardizing the Metric and Increasing the Efficiency of Physical Functioning Outcomes Measurement

    Nov 1, 2012, 00:00

  • PMS66 The Myotonic Dystrophy Type-1 Health Index (MDHI)- An Analysis of its Ability to Differentiate Between Clinically Distinct Populations

    Nov 1, 2012, 00:00

  • PCN85 Economic Assessment of the Oncotype DX Breast Cancer Assay

    Nov 1, 2012, 00:00

  • ME4 Using Discrete Choice Experiments to Value Health States for Economic Evaluation – the SF-6D in Australia

    Nov 1, 2012, 00:00

  • PRS9 Comparison of Knowledge About Tuberculosis among Libyan and Non Libyan TB Patients in North East Libya

    Nov 1, 2012, 00:00

  • PMD60 The Costs-Effectiveness of 3M™ CobanTM 2 Layer Compression System (Coban 2) for the Treatment of Lymphoedema in the Netherlands

    Nov 1, 2012, 00:00

  • PMS56 Impact of Compliance on Fracture Risk for Osteoporosis in Postmenopausal Women in Hungary

    Nov 1, 2012, 00:00

  • PSS7 Cost Effectiveness Analysis of Community Screening for Glaucoma in India

    Nov 1, 2012, 00:00

  • PRM10 Overview of the Prolabels Database Six Years After Its Implementation

    Nov 1, 2012, 00:00

  • PHP202 Bridging the Gap Between Institutional Levels Using Systems Analysis

    Nov 1, 2012, 00:00

  • PMH54 ADHD Among Adults in Five Western European Countries- An Analysis of National Health and Wellness Survey Data

    Nov 1, 2012, 00:00

  • PCN29 Initial Treatment and Survival Among Elderly Patients With Advanced Breast Cancer by Estrogen Receptor and Progesterone Receptor Status- An Analysis of United States National Registry Data 2000-2009

    Nov 1, 2012, 00:00

  • PCV32 A Non-Clinical Randomized Controlled Trial Assessing Impact of Pharmacists Led Intervention Programme for Enhancing Medication Adherence and Health-Related Quality of Life

    Nov 1, 2012, 00:00

  • PSU29 French Survey on the Management of Anemia and Iron Supplementation in Patients in Elective Orthopedic Surgery

    Nov 1, 2012, 00:00

  • PDB41 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in Algeria

    Nov 1, 2012, 00:00

  • PND33 Cost-Effectiveness Analysis of Genetic Testing of First-Degree Relatives at Risk of Sudden Cardiac Death Due to Gene-Related Cardiopathies in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PHP11 Availability and Pricing of Innovative Pharmaceuticals in the Top 5 European Pharmaceutical Markets

    Nov 1, 2012, 00:00

  • PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression- Cost-Utility and Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCN32 Treatment Patterns and Outcomes of Melanoma Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PDB15 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus Throughout the World- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PMS47 The Health and Economic Consequences of Delay in Starting Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in Ireland

    Nov 1, 2012, 00:00

  • PRM25 Issues and Uncertainties in Combinations of Diagnostic Technologies- A Case Study in Epilepsy Surgery

    Nov 1, 2012, 00:00

  • PHP96 Evidence Based Structural Reform in the Provision of Hospital Care- The Case Study of Merging Two Institutions in Hungary

    Nov 1, 2012, 00:00

  • PCN7 Angiotensin-Converting Enzyme Inhibitors Enhance the Effect of Cyclooxygenase Inhibitors on Breast Cancer - A Nationwide Case-Control Study

    Nov 1, 2012, 00:00

  • PRM46 Development of a Framework for Cost-Effectiveness Analysis Cohort Simulation Using an Ordinary Differential Equation Solver Algorithm in R

    Nov 1, 2012, 00:00

  • PDB32 Outcomes and Perceptions of 4MM Pen Needle Use in Diabetes Patients- Results From a Multi-Center Survey Pilot Study in Hong Kong

    Nov 1, 2012, 00:00

  • PND46 Relationship Between Patient Adherence to Treatment and Spanish Hospital Pharmacy'S Unmet Needs for the Management of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PMS81 Cost-Effectiveness and Budget Impact of Certolizumab Pegol Against a Mix of Treatments in an Outcomes-Based Risk-Sharing Scheme in Finland

    Nov 1, 2012, 00:00

  • PMH21 Cost-Effectiveness of Intramuscular Ziprasidone for the Treatment of Acute Agitation Associated to Schizophrenia in Mexico

    Nov 1, 2012, 00:00

  • PCN32 Quality of Life of Cancer Patients Receiving Capecitabine Monotherapy at Nakhon Pathom Hospital Nakhon Pathom Hospital

    Nov 1, 2012, 00:00

  • PIN77 Elicitation of Health-Related Quality of Life Concepts Associated With Cytomegalovirus in Transplant Recipients

    Nov 1, 2012, 00:00

  • PIN89 European Reference Pricing for Vaccines in Germany- Mechanics and Effects

    Nov 1, 2012, 00:00

  • PSY40 Health-Related Quality of Life and Annual Direct Medical Cost of Patients With Haemophilia B in Fran The EQOFIX Study

    Nov 1, 2012, 00:00

  • PRM126 Choice-Based Valuation of the SF-12v1

    Nov 1, 2012, 00:00

  • PCN56 Preliminary Results from a Study of Hospital Costs Due to Treatment of Head and Neck Cancers in England

    Nov 1, 2012, 00:00

  • PGI15 Comparison of Knowledge, Attitude and Practice Among Hepatitis-B Patients and Healthy Population Regarding Hepatitis-B

    Nov 1, 2012, 00:00

  • PSY12 The Cost of Treating Chronic Myeloid Leukemia (CML) in Greece

    Nov 1, 2012, 00:00

  • PIN5 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Community-Acquired Pneumonia (CAP)- A Network Meta-Analysis (NMA)

    Nov 1, 2012, 00:00

  • PHS8 Use of Health Care Administrative Databases to Estimate Incidence of Foot Complications in Diabetes Patients

    Nov 1, 2012, 00:00

  • PND72 Access, Uptake and Utilization Management of Multiple Sclerosis Products in the United States

    Nov 1, 2012, 00:00

  • PHP117 SMC Decisions- Are They Getting Tougher?

    Nov 1, 2012, 00:00

  • PCN132 Duration of Gefitinib Treatment in EGFR Mutation Positive NSCLC Patients in a UK Single Payement Access Scheme (SPA)

    Nov 1, 2012, 00:00

  • PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer

    Nov 1, 2012, 00:00

  • PRS19 Cost-Benefit Analysis of Tiotropium and Salmeterol Treatment Compare to Usual Practice on Sample of Employed Economicaly Active COPD Patients in Ukraine

    Nov 1, 2012, 00:00

  • PRM177 What is the Role of Early Health Technology Assessment of Biomarkers in the Pre-Clinical Development Phase? A Reflection on Lessons Learned With Multiple Myeloma

    Nov 1, 2012, 00:00

  • PIH43 Comparison of Unintended Pregnancy Rates Among Women Who Initiated Oral Contraceptive Therapy with a 84/7 Estradiol or a 84/7 Placebo

    Nov 1, 2012, 00:00

  • PIH3 Pregnancy Outcomes Folowing Exposure to Serotonin Reuptake Inhibitors- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM39 Survival Curve Convergences and Crossing- A Threat to Validity of Meta-Analysis?

    Nov 1, 2012, 00:00

  • PCV9 Association Between Persistence With Statins and Reduction of Low Density Lipoprotein Cholesterol- Analysis of Real-Life Data from Community Settings

    Nov 1, 2012, 00:00

  • PND5 A Mixed Treatment Comparison of Gabapentin Enacarbil, Pramipexole, Ropinirole and Rotigotine in Moderate-to-Severe Restless Legs Syndrome (RLS)

    Nov 1, 2012, 00:00

  • PIN85 Burden of Methicillin-Resistant Staphylococcus Aureus Bacteremia on Hospitals in the United States- Results From a National Database

    Nov 1, 2012, 00:00

  • PDB31 The Relationship Between the Cost of Disease and the Presence of Ophthalmic Complications in Type 2 Diabetes Mellitus is Determined via the Concomitant Complications Other Than Ophthalmic Complications

    Nov 1, 2012, 00:00

  • PIH23 A Discrete Event Simulation Model Used for Pharmacoeconomic Evaluation of Omegaven® in the Chinese Setting

    Nov 1, 2012, 00:00

  • PRM168 An Integrated Formal Framework for Reimbursement, Research and Pricing Deliberations in Health Technology Assessment

    Nov 1, 2012, 00:00

  • PDB20 Estimating the Direct Medical Costs Associated with Diabetes-Related Complications in Indonesia

    Nov 1, 2012, 00:00

  • PR2 A Feasibility Study of Preference-Based Health-Related Quality of Life Measures on Patients With Irritable Bowel Syndrom in Taiwan

    Nov 1, 2012, 00:00

  • PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic Encephalopathy

    Nov 1, 2012, 00:00

  • PIH42 Effectiveness of a Protocol for Respiratory Syncytial Virus (RSV) Immunoprophylaxis in Pre-Term Infants Born at 34 Weeks Gestation Age

    Nov 1, 2012, 00:00

  • PSU4 Regional Variation in Angiogram Use for Patients Who Underwent Coronary Artery Bypass Graft Surgery

    Nov 1, 2012, 00:00

  • PHP84 The Economic Health Value from Rx to OTC Switch in Greece

    Nov 1, 2012, 00:00

  • PHP12 Patented Drug Extension Strategies on Health Care Spending- A Cost-Evaluation Analysis

    Nov 1, 2012, 00:00

  • PMS24 Direct and Productivity Costs of Rheumatoid Arthritis in the Slovak Republic – Cost-of-Illness Study

    Nov 1, 2012, 00:00

  • PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

    Nov 1, 2012, 00:00

  • PIH5 Provider Payment and Cost of Treatment for Complicated Delivery Care- Evidence From Case Studies in Indonesia

    Nov 1, 2012, 00:00

  • PCN22 Immunotherapy With Sipuleucel-T (APC8015) in Patients With Metastatic Castration-Refractory Prostate Cancer (mCRPC)- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM38 Estimation of a Markov Chain for Crohn's Disease and Classification of Patients Into Disease Phenotypes, in Eight Countries Using Individual Longitudinal Data Aggregated Over Time

    Nov 1, 2012, 00:00

  • PRM167 The Value of Choice in a Collectively Funded Health System- An Extended Analytical Approach to Examine the Conflict Between Decisions at Individual and Societal Level

    Nov 1, 2012, 00:00

  • PCN118 Impact of Bone Metastases on Quality of Life in Patients With Castration-Resistant Prostate Cancer (CRPC) at High Risk for Developing Bone Metastases

    Nov 1, 2012, 00:00

  • PIN24 Clinical and Economic Evaluation of an Adult Pneumococcal Vaccination Programme Aimed at the Spanish HIV Population

    Nov 1, 2012, 00:00

  • PDB25 HbA1C Targets for Patients With Type 2 Diabetes- Results of a Systematic Literature Review

    Nov 1, 2012, 00:00

  • NI1 Three Years of Nice Scientific Advi Comprehensive Analysis of Requests to the Programme

    Nov 1, 2012, 00:00

  • PIN33 Corsar-Study (Cost and Resource Utilisation Study in Antiretroviral Treated Patients)

    Nov 1, 2012, 00:00

  • PHS35 The Distribution of Outpatient Physiotherapy Services in Hungary

    Nov 1, 2012, 00:00

  • PIH38 Capturing Quality of Life in Conditions with Fluctuating Symptoms

    Nov 1, 2012, 00:00

  • PND68 Comparison of Hospitalizations Among Parkinson'S Patients Who Initiated Therapy With a Dopamine Agonist or Rasagiline- Evidence From the Medicare Supplemental Database

    Nov 1, 2012, 00:00

  • PHP85 The Use of Biomarkers in Cancer Trials in Asia

    Nov 1, 2012, 00:00

  • PMS38 Cost-Effectiveness of Tapentadol for Severe Chronic Non-Cancer Pain in Belgium

    Nov 1, 2012, 00:00

  • PSU11 Medical Costs Comparison Between Internal Fixation and Arthoplasty in Patients With Hip Femoral Neck Fractures

    Nov 1, 2012, 00:00

  • PHP188 Funding the Unfundable- The Australian Approach for Specialty Pharmaceuticals

    Nov 1, 2012, 00:00

  • PSY9 Real-Life Cost-Analyses of Chronic Low-Back Pain Patients With Neuropathic Pain Components in Denmark

    Nov 1, 2012, 00:00

  • PHP1 A Qualitative Exploration of Malaysian Cancer Patients' Perceptions Towards Cancer Screening

    Nov 1, 2012, 00:00

  • PCN140 The Evaluation of Health Care Resource Utilization in Patients With Metastatic Castration Resistant Prostate Cancer- Results of a Multinational Observational Study

    Nov 1, 2012, 00:00

  • PND14 Budgetary Impact of the Treatment of Relapsing-Remitting Multiple Sclerosis in Spain

    Nov 1, 2012, 00:00

  • PIH20 Cost-Effectiveness of Supplemental N-3 in Total Parenteral Nutrition Therapy in the Italian, French, German and UK Context- A Discrete Event Simulation Model

    Nov 1, 2012, 00:00

  • PSU13 Survival and Cost Comparison of Balloon-Kyphoplasty and Vertebroplasty Using German Claims Data

    Nov 1, 2012, 00:00

  • PHP116 Orphan Drug Pricing and Access – Current Situation and Future Trends in EU

    Nov 1, 2012, 00:00

  • PCN145 Observational Macro Analysis on the Aggregated Cigarette Price Elasticity in Denmark 1978-2010

    Nov 1, 2012, 00:00

  • PHS56 Evaluation of Telemedicine Program (ITHACA)- Innovation in the Treatment of Arterial Hypertension Increasing the Compliance and Adherence

    Nov 1, 2012, 00:00

  • PMH13 Longitudinal Analysis of Patient Level Health Care Costs in Patients With Major Depressive Disorder Treated With Duloxetine

    Nov 1, 2012, 00:00

  • PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression Fractures

    Nov 1, 2012, 00:00

  • PHP3 Adherence to the Clinical Practice Guidelines in the Management of Chronic Ischemic Heart Failure in a District Hospital

    Nov 1, 2012, 00:00

  • PCN152 Patient-Relevant Endpoints (PRE) in Oncology - Current Issues in the Context of Early Benefit Assessment (EBA) in Germany- An Industry Perspective

    Nov 1, 2012, 00:00

  • PCN69 Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab (MabThera) for Non-Hodgkins Lymphoma Patients in Greece, a Local Adaptation

    Nov 1, 2012, 00:00

  • PMS24 A Systematic Review of Existing Utility Weight Estimates in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PCV16 Associations Between Patient Demographics, Pharmacotherapy Use, and Cost, Resource Utilization, and Quality-of-Life Burden in Adult Cardiac Arrhythmia Patients

    Nov 1, 2012, 00:00

  • PMD93 Practice Variation in Diagnostic Imaging Workup and Treatment Criteria Following a Recent TIA or Minor Ischemic Stroke- Consequences for Early Economic Evaluations

    Nov 1, 2012, 00:00

  • PMD30 Short Term Health-Economic Outcomes of Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes- A Cost Comparison Analysis

    Nov 1, 2012, 00:00

  • PIN71 The Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in Kazakhstan

    Nov 1, 2012, 00:00

  • PHP84 Lung Cancer Treatment- A Paradigm Shift to Targeted Therapies in Clinical Trial Settings in Asia

    Nov 1, 2012, 00:00

  • DU3 Market Access Delays for CNS Drugs in Europe

    Nov 1, 2012, 00:00

  • PMD41 Economic Evaluation of Continuous Subcutaneous Insulin Infusion for Children With Diabetes – a Pilot Study

    Nov 1, 2012, 00:00

  • PCV7 A Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients with Non-Valvular Atrial Fibrillation (NVAF)

    Nov 1, 2012, 00:00

  • PHP94 Determinants of Drug Therapy Problems among Medicaid Patients Receiving a Telephonic Medication Therapy Management Program

    Nov 1, 2012, 00:00

  • PIN18 Antimicrobial Resistance (AMR) in Thailand- A Systematic Review

    Nov 1, 2012, 00:00

  • PHS97 An Off-the-Shelf Catalogue of Quality Improvement Interventions to Implement in the Prevention of Pressure Ulcers for Hospital Settings

    Nov 1, 2012, 00:00

  • PHP94 Effectiveness and Cost-Benefit of a Bupivacaine Physician Educational Programme in Minimizing the Spinal Anesthesia Failure Rate- Report from a Tertiary-Care Hospital in Central Taiwan

    Nov 1, 2012, 00:00

  • PMS78 Demographİc and Socİoeconomİc Characterİstİcs That Affect Selectİon of İntravenous Versus Subcutaneous İnjectİon Tumor Necrosis Factor Inhİbitors for Rheumatoid Arthritis Patients

    Nov 1, 2012, 00:00

  • PSS11 Economic Evaluation of Biologic Treatments for Moderate to Severe Psoriasis in Italy

    Nov 1, 2012, 00:00

  • PDB30 The Prevalence and Burden of Comorbid Hypertension and Obesity among Patients With Type 2 Diabetes in Japan

    Nov 1, 2012, 00:00

  • PIN1 Effect of Antitubercolosis Treatment on Lever Enzymes

    Nov 1, 2012, 00:00

  • PRM105 Predicting Subjective Antimuscarinic Effectiveness on Symptoms of Overactive Bladder Using the Eight-Item Overactive Bladder Awareness Tool (OAB-V8)

    Nov 1, 2012, 00:00

  • PHP201 Can Risk Management Plans (RMP) Contribute to Health Technology Assessment (HTA) and Knowledge of Safety in Everyday Medical Practice?

    Nov 1, 2012, 00:00

  • PIN88 Cost Implications of Different Practices in Vaccine Provision

    Nov 1, 2012, 00:00

  • CL4 Marginal Structural Models Used in Estimating Cost-Effectiveness of Time-Varying Drug Therapy Using Adimistrative Databases. The Case of Statin in Secondary Prevention

    Nov 1, 2012, 00:00

  • PRM171 Optimal Shopping- An Evauation of Decision Rules in Cost-Effectiveness Analysis (CEA)

    Nov 1, 2012, 00:00

  • PIH39 Occupational Stress and Burnout- Impact on the Attitudes of Pharmacists in Providing Pharmaceutical Services

    Nov 1, 2012, 00:00

  • PGI5 Increasing Demands for Medical and Drug Utilization in Patients With Long-Term Irritable Bowel Syndrome in Taiwan

    Nov 1, 2012, 00:00

  • PIN20 Budget Impact of Backbone Choice in Italian Treatment- Naïve, HIV-Infected Patients

    Nov 1, 2012, 00:00

  • PCN27 Analysis of Prevalence and Treatment of Multiple Myeloma in German Statutory Sick Funds Claim Data

    Nov 1, 2012, 00:00

  • PIN74 Cost Savings Due to Antibiotic Prescription Related to Quick C-Reactive Protein Testing

    Nov 1, 2012, 00:00

  • PCV122 Hypertension and Disability-Free Life Expectancy From a Cohort Study in Japan –Results From a Nationwide Cohort Study (NIPPON DATA80/90)

    Nov 1, 2012, 00:00

  • PCV98 Health Related Quality of Life and Age in Hypertensive Patients- Self-Perception and Evaluation by Professionals. The Equality Study

    Nov 1, 2012, 00:00

  • PGI9 Analysis of Adherence With Oral 5-Aminosalicylic Acid (5-ASA) Therapy in Patients with Ulcerative Colitis (UC) in a Uk Pharmacy Database

    Nov 1, 2012, 00:00

  • PIH33 Utility and Human Capital Loss in Asthma, Chronic Obstructive Pulmonary Disease and Rheumatoid Arthritis – The Impact of Prevalence, Disease Specific Mortality and Utility Decrement on Overall Health Burden

    Nov 1, 2012, 00:00

  • PGI7 Adherence to 5-Aminosalicylic Acid (5-ASA) Therapies in Ulcerative Colitis (UC)- A UK Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PRM14 Proposed Checking Points to Evaluate Report of Multiple Treatment Comparison (MTC) Analysis in the Submission of New Drug Reimbursement and Pricing Application to the National Health Insurance in Taiwan

    Nov 1, 2012, 00:00

  • PMD79 A Population-Based Study on the Use of Blood Glucose Monitoring Test Strips

    Nov 1, 2012, 00:00

  • PHS43 Cost-Effectiveness Analysis of Therapeutic Drug Monitoring in Pediatric Patients Diagnosed With Structural-Metabolic Epilepsy

    Nov 1, 2012, 00:00

  • PHP22 Pharmacovigilance in Qatar – a Pharmacist Survey

    Nov 1, 2012, 00:00

  • PCV35 Costs of Treating Cardiovascular Diseases in Germany- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PMD27 Budget Impact of Selecting Cardiac Resynchronization Therapy (CRT) Devices With Adaptive (“ACRT”) Programming Algorithms Under the United States Medicare Payment Setting

    Nov 1, 2012, 00:00

  • PIN75 Health-Related Quality of Life of Clostridium Difficile Infection- A Methodological Contribution to Direct Utility Elicitation by TTO

    Nov 1, 2012, 00:00

  • PSU14 Economic Impact of Scoliosis in Canada- A RAMQ Database Analysis

    Nov 1, 2012, 00:00

  • PND70 Patient Characteristics and Treatment Status in Parkinson'S Disease (PD)

    Nov 1, 2012, 00:00

  • CA4 A Comparison of Patient and General-Population Utility Values for Advanced Melanoma in Health Economic Modelling

    Nov 1, 2012, 00:00

  • PDB35 Validation of the Problem Areas in Diabetes Questionnaire Among Patients With Type 2 Diabetes Mellitus in Singapore- a Pilot Study

    Nov 1, 2012, 00:00

  • EX3 A Evaluation of the Effects from China Drug Policy Reform During 2009-2011- Some Success, Many Unintended Effects

    Nov 1, 2012, 00:00

  • CV4 Evaluation of Telemonitoring for Heart Failure Patients With Implantable Defibrillators- The Evolvo (Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators) Study

    Nov 1, 2012, 00:00

  • PHP144 Economic Effect of Clinical Trials for Turkey

    Nov 1, 2012, 00:00

  • PHS2 Population Risk Stratification- Based on the Cost of Care in Patients With Chronic Diseases

    Nov 1, 2012, 00:00

  • PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in Turkey

    Nov 1, 2012, 00:00

  • PMD88 Disparities in Access to EGFR-Mutation Testing in Patients With Advanced NSCLC in Germany 2011

    Nov 1, 2012, 00:00

  • PRS37 Quality of Life in Paediatric Asthma From Patient and Their Parents Perspective

    Nov 1, 2012, 00:00

  • PSY16 Cost Utility Analysis of Reduced Intensity Hematopoietic Stem Cell Transplantation in Adolescence and Young Adult With Severe Thalassemia Compared to Hypertransfusion and Iron Chelation Program

    Nov 1, 2012, 00:00

  • PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations

    Nov 1, 2012, 00:00

  • PDB28 Economic Evaluation of Vildagliptin As Add-on Therapy to Metformin in Diabetes Mellitus Treatment in China

    Nov 1, 2012, 00:00

  • PUK6 The Economic Burden of Post-Transplant Events in Renal Transplant Patients in Germany (The Portrait Study)

    Nov 1, 2012, 00:00

  • PHS22 Burden of Invasive Pneumococcal Diseases in Older Adults in the New EU Countries of the Central Europe

    Nov 1, 2012, 00:00

  • PIN44 Cost-Effectiveness of Posaconazole Compared to Fluconazole/Itraconazole for the Prevention of Invasive Fungal Infections in Neutropenic Patients

    Nov 1, 2012, 00:00

  • PCN35 Survival Estimates of Six Major Advanced and Metastatic Solid Tumors in Europe- A Cancer Registry and Literature Review

    Nov 1, 2012, 00:00

  • PCV29 Health Care Resource Utilization and Costs of Cardioembolic Stroke in the Region of Madrid, Spain- Preliminary Results of CODICE Study

    Nov 1, 2012, 00:00

  • PMH3 Caregiver Perceptions on the Burden of Caring for Dementia Patients- Results from a Cross-Sectional Hospital-Based Study in China

    Nov 1, 2012, 00:00

  • PRM149 A Random Utlity Model Using a Transaction Cost Politics Approach to Adjust Health Systems to Economic Transition

    Nov 1, 2012, 00:00

  • PMD83 The Cost Impact of Modifying Patterns of Self-Monitoring of Blood Glucose in an Irish Type 2 Diabetes Cohort

    Nov 1, 2012, 00:00

  • PCV31 Cost of Cardiovascular Diseases in Serbia

    Nov 1, 2012, 00:00

  • PCV32 The Cost of Diabetes Complications in Belgium

    Nov 1, 2012, 00:00

  • PHP142 Drug Shortages Around the World and the Underlying Reasons

    Nov 1, 2012, 00:00

  • PND60 Non-Diabetic Peripheral Neuropathic Pain is Underdiagnosed in GP Practices Although it has High Impact on Patients' Health Related Quality of Life

    Nov 1, 2012, 00:00

  • PHS23 Direct Medical Costs Associated With Stroke in Non-Valvular Atrial Fibrillation in India

    Nov 1, 2012, 00:00

  • PCV54 Economic Evaluation of Rivaroxaban in the Treatment of Deep Vein Thrombosis in Greece

    Nov 1, 2012, 00:00

  • PHP64 Evaluation of Public Perception Towards Medicine Quality and Prices in Afghanistan

    Nov 1, 2012, 00:00

  • PMD44 Evaluating Strategies for Using DNA Testing to Identify Mucinous Pancreatic Cysts

    Nov 1, 2012, 00:00

  • PCV57 Cost-Effectiveness of Ivabradine in Thai Heart Failure Patient

    Nov 1, 2012, 00:00

  • PHP109 Practice Change in Italian Community Pharmacy- An Analysis of Managerial Implication

    Nov 1, 2012, 00:00

  • PCN150 Comparisons of QALYs Gained, Cost Per QALY Gained and ASMRs for 38 Anticancer Drugs in France and the UK- Vive La Difference?

    Nov 1, 2012, 00:00

  • PIH18 Clinical Efficacy and Cost-Effectiveness of Additional Immunotherapy in Early-Onset Neonatal Infections

    Nov 1, 2012, 00:00

  • PHP164 Payer Information Requirements for Relative Effectiveness Assessment Vary Across Markets and Create Discrepencies in Patient Access to Medicines

    Nov 1, 2012, 00:00

  • PRM6 The UK Contribution to Real World Research- Review of Published Data at ISPOR, Madrid 2011

    Nov 1, 2012, 00:00

  • PDB22 Potential Budget Impact of Linagliptin in France Estimated From Current Pattern of Dipeptidyl Peptidase 4 Inhibitors Prescriptions

    Nov 1, 2012, 00:00

  • PHS10 HbA1c Testing Frequency in Primary Care Diabetes Patients in Germany and in the UK

    Nov 1, 2012, 00:00

  • PHS88 Pharmacist House Calls in Home Care in Japan

    Nov 1, 2012, 00:00

  • PUK17 Cost-Mimimization Analysis of Pazopanib Versus Sunitinib, Sorafenib and Bevacizumab+ Interferon á-2a for Patients With Metastatic Renal Cell Carcinoma

    Nov 1, 2012, 00:00

  • PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in Italy

    Nov 1, 2012, 00:00

  • PIH6 Unintentional Exposures to Buprenorphine/Naloxone Tablets and Oral Film among Children Less Than Six Years Old

    Nov 1, 2012, 00:00

  • PND6 Combining RCT and Observational Data in a Mixed Treatment Comparison of Disease-Modifying-Therapies for Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PMD91 Scenario Analysis and Real Options Modeling of Home Brain Monitoring in Epilepsy Patients

    Nov 1, 2012, 00:00

  • PCN104 Profile of Patients and Health Care Costs Associated With Cancer Treatment From a Medical Cooperative in the State of São Paulo, Brazil

    Nov 1, 2012, 00:00

  • PRS18 Systematic Review of Economic Evaluations, Utility Estimates, Resource Utilisation, and Costs in Chronic Idiopathic Urticaria

    Nov 1, 2012, 00:00

  • PSY24 Economic Evaluation of Opioid Substitution Treatment (OST) in Greece

    Nov 1, 2012, 00:00

  • PHP67 Review of the Currently Listed Drugs in South Korea

    Nov 1, 2012, 00:00

  • PRM131 How Might Experience-Based Utility Measures Influence Reimbursement Decisions?

    Nov 1, 2012, 00:00

  • PCV110 Multivariate Analysis of Clinical and Patient-Level Factors Associated With Colesevelam Treatment Persistence

    Nov 1, 2012, 00:00

  • PCV73 Prevention of Stroke in Patients With Atrial Fibrillation- Cost-Utility Analysis of Rivaroxaban Versus Warfarin in Slovakia

    Nov 1, 2012, 00:00

  • PHP111 Factors Predicting Reimbursement Decisions on Orphan Drugs in Eight Countries

    Nov 1, 2012, 00:00

  • PSY45 Social Economic Burden and Health-Related Quality of Life in Patients With Rare Diseases in Europe (BURQOL-RD Project). Spanish Results

    Nov 1, 2012, 00:00

  • PCN53 Real World Management and Costs in Metastatic Malignant Melanoma (MM) Patients- A Pilot Study Based on an Institutional Patient Registry

    Nov 1, 2012, 00:00

  • PRM120 Pathways to Effective Clinro Dossier Development

    Nov 1, 2012, 00:00

  • PCV106 Affordability of Anti-Hypertensive Medication in Egypt Under Current Reimbursement Systems

    Nov 1, 2012, 00:00

  • PHP50 Integrated Closed Intravenous Catheter System Reduces the Occurrence of the Catheter Replacement and the Cost

    Nov 1, 2012, 00:00

  • PUK3 Evaluation of Medication-Related Problems in Hemodialysis Patients

    Nov 1, 2012, 00:00

  • PCN39 Potential Time and Cost Savings with Herceptin (Trastuzumab) Subcutaneous (SC) Injection Versus Herceptin Intravenous (IV) Infusion- Results from Three Different English Patient Settings

    Nov 1, 2012, 00:00

  • PHS31 Determination of the Annual Health Insurance Cost of Outpatient Care Physiotherapy Services for Musculoskeletal and Connective Tissue Diseases

    Nov 1, 2012, 00:00

  • PRM24 Economic Valuation of Informal Care – Task Based Approach

    Nov 1, 2012, 00:00

  • PHP32 Understanding Accessibility for New Medicines Entering the Market Since 2007 in Portugal Using Survival Analysis

    Nov 1, 2012, 00:00

  • PHP71 Cost Effectiveness Analysis of Facility and Community Based Provision of Family Planning in Kampala

    Nov 1, 2012, 00:00

  • RU2 Potential Time Savings With Trastuzumab Subcutaneous (SC) Injection Versus Trastuzumab Intravenous (IV) Infusion- Results from Interviews Conducted As Part of a Time-and-Motion Study (TM) Across 17 Sites

    Nov 1, 2012, 00:00

  • PCN21 Comparative Effectiveness and Cost-Effectiveness Assessment of Erlotinib Versus Gefitinib in First-Line Treatment of EGFR Activating Mutation Positive Non-Small Cell Lung Cancer for Hong Kong

    Nov 1, 2012, 00:00

  • PCN57 Economic Burden of Prostate Cancer in Russia

    Nov 1, 2012, 00:00

  • PCN14 Acute Myeloid Leukaemia Treatment Pathways - a Detailed Costing Study Example

    Nov 1, 2012, 00:00

  • PA1 Assessing the Progression of the UK NHS Health Care Reforms and the Impact on Health Care Delivery

    Nov 1, 2012, 00:00

  • PHP115 The Sharp Decrease of Drug's Access to Reimbursement in France in 2011

    Nov 1, 2012, 00:00

  • PHP41 Use of Special Payments to Encourage the Adoption of Innovative Medical Technologies in the English NHS

    Nov 1, 2012, 00:00

  • PA3 Limited Access to Cataract Surgery in Poland

    Nov 1, 2012, 00:00

  • PIH30 Potentially Inappropriate Prescribing and Adverse Health Outcomes in Community Dwelling Older Populations

    Nov 1, 2012, 00:00

  • PRM161 A Paradigm Shift in Health Economic Evaluations for Developing Countries - Optimization Modelling for Assessing Which Mix of Malaria Prevention Strategies Achieves a Defined Public Health Target at the Lowest Budget

    Nov 1, 2012, 00:00

  • PHP160 Benefits of Probabalistic Sensitivity Analysis

    Nov 1, 2012, 00:00

  • PIH41 Long-Term Fiscal Implications of Funding Assissted Reproductive Therapies- Review of the Literature

    Nov 1, 2012, 00:00

  • PRM56 Development of a Conceptual Model for Use in Economic Modelling of Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2012, 00:00

  • PCN78 Cost-Effectiveness of Plerixafor Plus GCSF for Mobilization of Peripheral Blood Stem Cells in Patients With Myeloma and Lymphoma in Spain

    Nov 1, 2012, 00:00

  • PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting

    Nov 1, 2012, 00:00

  • MA3 Paliperidone Palmitate Long-Acting Injection for Brazilian Non-Adherent Schizophrenic Patients- 5-Year Budget Impact Analysis From the Public Payer Perspective

    Nov 1, 2012, 00:00

  • PMH8 A Review of Consequences of Relapse in Schizophrenia

    Nov 1, 2012, 00:00

  • PHS15 Recommendation for Rotavirus Vaccination and Herd Effect- Analyzing Cost Data from a German Statutory Health Insurance

    Nov 1, 2012, 00:00

  • PRS1 Cost-Utility of Molecular IgE in Vitro Diagnostics (IVD) in Children Suspected With Peanut Allergy Compared to Most Used Diagnostics in Selected Asian Markets

    Nov 1, 2012, 00:00

  • PHP92 The Impact of the Surveillance in Pharmacotherapy by Hospital Health Care Risks Management (HHRM)

    Nov 1, 2012, 00:00

  • PHP136 Generic Price Linkage As a Policy Choi Review of Recent Developments

    Nov 1, 2012, 00:00

  • PIN52 Pharmacoeconomical Aspects of Treating Acute Bronchitis Among Adults

    Nov 1, 2012, 00:00

  • PGI11 Association Between Knowledge and Health Related Quality of Life in Hepatitis B Patients

    Nov 1, 2012, 00:00

  • PIN56 Economic Value of Telaprevir for the Treatment of Previously Untreated F2 Fibrosis Chronic Hepatitis C Patients

    Nov 1, 2012, 00:00

  • PHP199 The Impact of the German Pharmaceutical Market Reorganisation Act (AMNOG) on the German Reference Price Market – Trends Two Years After the Introduction of the AMNOG

    Nov 1, 2012, 00:00

  • PMS64 Comparative Efficacy of Tocilizumab and aTNF Biologic Monotherapies on Patient Reported Outcomes (PROs) in RA Patients Who Have Shown an Inadequate Response to Conventional DMARDs (DMARD-IR)- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM58 Long-Term Validation of the IMS CORE Diabetes Model in Type 1 and Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PCN147 A Cross European Comparison of Eribulin Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PND25 Burden of Spina Bifida (SB) in Germany - the Characteristics of SB Population

    Nov 1, 2012, 00:00

  • PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov Model

    Nov 1, 2012, 00:00

  • PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

    Nov 1, 2012, 00:00

  • PUK7 Cost of Illness of Overactive Bladder Syndrome in Hungary

    Nov 1, 2012, 00:00

  • PCN130 Role of the Health Care Payment System on the Patient Access to Oral Anticancer Drugs- A Comparison of French and North American Situations

    Nov 1, 2012, 00:00

  • PCV6 Comparison Rivaroxaban with Other Antithrombotic Agents- Effectiveness and Safety of Prophylactic Antithrombotic Agents After Major Orthopedic Surgeries in Taiwan

    Nov 1, 2012, 00:00

  • PRM90 Outcome Differences in Algorithms Used for Indirect Mapping of Utility Values From HAQ-DI- An Assessment Based on Phase 2A Clinical Trial Data in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-II-20 MAB)

    Nov 1, 2012, 00:00

  • PDB58 The Psychometric Performance of the EQ-5D, SF-6D and Diabetes Health Profile (DHP-18) in Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PRM22 Testing the Equivalence of the Label Wording for EQ-5D-5L Response Options Across Different Languages in Singapore

    Nov 1, 2012, 00:00

  • PRM122 Atopic Dermatitis on Families- Creation of a Specific Burden Questionnaire

    Nov 1, 2012, 00:00

  • PHP172 Challenges in Developing a New System for Registration of Patient Registries

    Nov 1, 2012, 00:00

  • PIN55 How Should We Target Cost-Efficacy in the Treatment of HIV-1 Naïve Patients With Recommended Therapies Based on NNRTIS in Spain?

    Nov 1, 2012, 00:00

  • PDB12 Role of Chromium in Type-2 Diabetes Therapy- A Systematic Review Study

    Nov 1, 2012, 00:00

  • PMS45 Exercise Therapy, Manual Therapy, or Both, for Management of Osteoarthritis of the Hip or Knee- Economic Evaluation Alongside a Randomized Clinical Trial

    Nov 1, 2012, 00:00

  • PMD70 A Five-Year Markov Model Evaluating the Cost-Utility of NASHA/Dx for the Treatment of Fecal Incontinen A United States Perspective

    Nov 1, 2012, 00:00

  • PMS17 The Societal Cost for RA Before and After the Introduction of Biological Drugs- a Swedish National Register Study for 1990-2010

    Nov 1, 2012, 00:00

  • PRS8 The Effect of Asthma on Health Status, Work Productivity, and Health Care Resource Use in Urban China

    Nov 1, 2012, 00:00

  • PUK16 Cost-Effectiveness of Ketosteril Treatment in Stage 3-4 CKD Patients

    Nov 1, 2012, 00:00

  • PHP78 Similar HTA, Different Access Outcome? Comparison of Orphan Oncology Drug Assessment in South Korea, Australia and the UK

    Nov 1, 2012, 00:00

  • PRM30 Hospitalization Registry and Costs of Benign Prostatic Hyperplasia Patients (BPH) Based on a Public Database (DATASUS) in Brazil

    Nov 1, 2012, 00:00

  • PRM5 Systematic Review of Cost-Utility Analyses in Asia

    Nov 1, 2012, 00:00

  • PRM68 Comparative Computation Speed of Excel, Visual Basic for Applications, R, and Java in Execution of a Microsimulation Model With Probabilistic Sensitivity Analysis

    Nov 1, 2012, 00:00

  • PCN17 Indirect Comparison of the Efficacy of Erlotinib Versus Pemetrexed Plus Cisplatin as First Line Treatment in Patients With Metastatic Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating Mutations

    Nov 1, 2012, 00:00

  • PUK9 Direct and Indirect Cost of Urge Urinary Incontinence With and Without Pharmacotherapy

    Nov 1, 2012, 00:00

  • PHS78 Impact of Educational Intervention on Case Management of ARI at Community Pharmacies in Islamabad Pakistan

    Nov 1, 2012, 00:00

  • PRM98 Optimizing Discrete Choice Experiment Designs Using Simulations

    Nov 1, 2012, 00:00

  • PCN148 Review of National Institute for Health and Clinical Excellence (NICE) Recommendations for Anti-Cancer Agents Across Multiple Drug-Indication Combinations

    Nov 1, 2012, 00:00

  • PDB12 How Hypoglycaemic Events Can Influence Diabetic Patients' Weight and Affect Hba1C Control

    Nov 1, 2012, 00:00

  • PHP55 Perception Towards Health Promotion Activities- Findings from a Cross Sectional Survey Among Urban Poor Population in the State of Penang, Malaysia

    Nov 1, 2012, 00:00

  • PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in Finland

    Nov 1, 2012, 00:00

  • PHP203 How to Optimise Chances for Successful AMNOG Assessments – Best Practice Approach for German Market Access

    Nov 1, 2012, 00:00

  • PSU17 The Cost of Surgical Procedure to Remove Adhesions Abdomen or Pelvis in the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PHP107 Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC Bridge Study- An Interim Analysis of HCC Burden of Illness in the Asia-Pacific (AP) Cohort

    Nov 1, 2012, 00:00

  • PND52 Validation of Spanish Version of the Huntington Clinical Self-Reported Instrument (H-CSRI)

    Nov 1, 2012, 00:00

  • QL3 Simulations of Adaptive Measurement of Change for Health Related Quality of Life Assesments in Chronic Conditions

    Nov 1, 2012, 00:00

  • PRM39 Evaluation of Patient Centered Outcomes Using Individual Data From a Quality Registry and Patient Reported Abilities and Ratings of Quality in Health Care, in Diabetes Patients in Sweden

    Nov 1, 2012, 00:00

  • PHP163 Assessing the Quality of Manufacturers' Searches in NICE Single Technology Appraisals by Evidence Review Groups

    Nov 1, 2012, 00:00

  • PUK1 Diuretic Activity of Aqueous Extract of Boswellia Serrata Roxb. Oleo Gum in Normal Albino Rats

    Nov 1, 2012, 00:00

  • PHP61 Excess Weekend Mortality in Hospitals- A Result of Higher Severity of Illness at the Time of Admissions?

    Nov 1, 2012, 00:00

  • PHP82 The Characteristics of Clinical Trials in Asia

    Nov 1, 2012, 00:00

  • PND31 Economic Value of Slowing Parkinson's Disease in Germany- Modeling Progression Through Hoehn and Yahr Stages

    Nov 1, 2012, 00:00

  • HC4 Tapping Into the Asian Pharmaceutical Market- Global Firms Go Local?

    Nov 1, 2012, 00:00

  • PCN64 Cost-Consequence Analysis (CCA) of the Treatment of Growing Subependymal Giant Cell Astrocytoma (SEGA) Secondary to Tuberous Sclerosis Complex (TSC) in Brazil

    Nov 1, 2012, 00:00

  • PMS52 Drug Use Profile in a Rheumatoid Arthritis Patient Cohort- A Brazilian Health Management Organization Experience

    Nov 1, 2012, 00:00

  • PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2012, 00:00

  • PRM17 Economic Evaluation of Vaccines- Considerations on Evidence, Discounting, Models and Futures Challenges

    Nov 1, 2012, 00:00

  • PHP87 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in Shenyang

    Nov 1, 2012, 00:00

  • PIH4 Network Meta-Analysis of Pharmacological Interventions to Prevent Venous Thromboembolism Following Elective Knee and Hip Replacement Surgery- Why Extend the Network?

    Nov 1, 2012, 00:00

  • PHS32 Determination of the Annual Health Insurance Cost of Outpatient Care Physiotherapy Services for Trauma Patients

    Nov 1, 2012, 00:00

  • PDB59 Content Validity of a New Patient-Reported Outcome Instrument to Assess Hypoglycemia- The Hypoglycemia Perspectives Questionnaire

    Nov 1, 2012, 00:00

  • PRM27 Evaluating European Data Sources for Assessing Real-World Effectiveness of New Anti-Diabetic Drugs

    Nov 1, 2012, 00:00

  • PHP99 Implementation of a Formulary Management Programme in Singapore

    Nov 1, 2012, 00:00

  • PMS40 Cost-Effectiveness of Denosumab for the Treatment of Male Osteoporosis (MOP) in the Elderly in Sweden

    Nov 1, 2012, 00:00

  • PCV76 Standard Costs and Resources Allocation in Attainment of Target Lipid Levels among Experienced Statin Users- Results From the STAR Study (Statins Target Assessment in Real Practice)

    Nov 1, 2012, 00:00

  • PHP78 System-Wide Impact of Payment Schemes for Integrated Care of Chronic Diseases in Europe- Evidence from an Empirical Analysis

    Nov 1, 2012, 00:00

  • PHP182 Concordance of PRO Labeling Claims Between the FDA and EMA

    Nov 1, 2012, 00:00

  • PDB15 A1C Variability is Associated With the Risk of Developing New Diabetes for the Healthy Adults

    Nov 1, 2012, 00:00

  • PCV43 Fair Cost-Benefit Evaluation of Health Care- A Case Study of Blood Pressure Lowering Drugs in France

    Nov 1, 2012, 00:00

  • PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

    Nov 1, 2012, 00:00

  • PMD69 Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation in the UK

    Nov 1, 2012, 00:00

  • PDB64 The Avoidance of Weight Gain is Important for Oral Type 2 Diabetes Treatments in Sweden and Germany- A Patient Preference Study

    Nov 1, 2012, 00:00

  • PHP14 2010-2012 Global Health Care Reforms and Their Impact on Pricing, Access and Health Outcomes Strategy

    Nov 1, 2012, 00:00

  • PHP146 Pharmacoeconomic Education for Pharmacy Students in the Russian Federation

    Nov 1, 2012, 00:00

  • PCN89 Cost Effectiveness of Treatment With New 6-Month Leuprorelin Acetate Formulation in Patients With Advanced Prostate Cancer

    Nov 1, 2012, 00:00

  • PHP44 Public Financing of Medicines in Portugal (2007-2011)- Accessibility to Medicinal Products with New Molecules or New Therapeutic Indications

    Nov 1, 2012, 00:00

  • PCV1 Evaluation of Statin-Associated Adverse Events- Analysis of the Incidence and Influence of the Concomitant Use of Potential Interacting Drugs

    Nov 1, 2012, 00:00

  • PSS31 Prevalence of Chronic Wounds in Germany — a Secondary Data Analysis

    Nov 1, 2012, 00:00

  • PIH48 Service Uses and Costs of Child and Adolescent Psychiatric Patients Treated with Antipsychotics in Taiwan

    Nov 1, 2012, 00:00

  • PCV97 Burden of Dyspepsia among Patients With Atrial Fibrillation in Japan

    Nov 1, 2012, 00:00

  • PCV68 Economic Evaluation of Initiation With Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension in Spain

    Nov 1, 2012, 00:00

  • PGI5 Effectiveness and Safety of Antacids in Pregnant Women Suffering From Gerd/Hyperacidity Symptoms

    Nov 1, 2012, 00:00

  • PCV34 The Economic Cost of Acute Coronary Syndrome in Turkey

    Nov 1, 2012, 00:00

  • MA2 Observation of Persistence Rates and Potential Cost Savings Associated With Certolizumab Pegol Treatment for Rheumatoid Arthritis in England, Wales and Northern Ireland Clinical Practice

    Nov 1, 2012, 00:00

  • PHS17 Costs of Influenza A(H1N1)2009 Infection During the Pandemic and the Postpandemic-Seasonal Waves

    Nov 1, 2012, 00:00

  • PUK24 Pharmacoeconomic Aspects of Use of Erythropoietin Drugs in Patients on Hemodialysis in Ukraine

    Nov 1, 2012, 00:00

  • PUK10 Comparative Cost-Analysis of Six Anticholinergics for the Treatment of Overactive Bladder and Incontinence in Germany

    Nov 1, 2012, 00:00

  • PIN12 Burden of Disease and Serotype Distribution Associated With Reportable Invasive Streptococcus Pneumoniae Pneumonia in Norway, 2007–2009

    Nov 1, 2012, 00:00

  • PHP16 Removing the Barrier of Cost to Smoking Cessation Medications Under the Affordable Care Act of 2010

    Nov 1, 2012, 00:00

  • PDB62 Type 2 Diabetes in Russia- Prevalence, Risk Factors, and Burden

    Nov 1, 2012, 00:00

  • PMS50 Indirect Costs of Rheumatoid Arthritis in Serbia Related to Work Absenteeism, Medical Welfare and Rehabilitation Costs

    Nov 1, 2012, 00:00

  • CL4 Drug Switching Events Among Users of NSAIDS With or Without Gastro-Protective Drugs As an Early Determinant of Dissatisfaction From Gastrointestinal Adverse Events

    Nov 1, 2012, 00:00

  • PHP113 Utilization of FPG, HbA1C and Self-Monitoring of Blood Glucose (SMBG) in Community Health Centers in the Shanghai Area

    Nov 1, 2012, 00:00

  • PCN5 Impact of Erythropoiesis Stimulating Agents on Survival among Patinets With Colorectal Cancer Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • CL2 Statistical Considerations in Estimating Survival for Economic Evaluations in Oncology

    Nov 1, 2012, 00:00

  • PIN40 Cost-Effectiveness of Boceprevir-Based Treatment of Chronic Genotype 1 Hepatitis C Virus (HCV) Infection From the Perspective of the German Statutory Health Insurance (SHI)

    Nov 1, 2012, 00:00

  • PSY49 Treatment Patterns in Psoriatic Arthritis (PSA) Patients Newly Initiated on Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)

    Nov 1, 2012, 00:00

  • PCN36 Vinorelbine in Patients With Non-Small Lung Cancer- Budget Impact Analysis

    Nov 1, 2012, 00:00

  • DU1 A Time Series Analysis of the Effect of the Co-Payment on Pharmaceutical Consumption in Two Italian Regions

    Nov 1, 2012, 00:00

  • PHP111 Development of National Medicine Brand Substitution Guidelines and Pilot Assessment of Its Adoptability among Community Pharmacist and General Practitioners in the State of Penang, Malaysia

    Nov 1, 2012, 00:00

  • PGI29 Cost of Chronic Hepatitis C (HCV) in Poland – Health Care Professionals Survey

    Nov 1, 2012, 00:00

  • PHP137 Changes in the Medicines Pricing and Reimbursement Approach in Bulgaria

    Nov 1, 2012, 00:00

  • PIN43 The Use of Futility Rules in Economic Evaluations With Direct Acting Agents (DAA) in the Treatment of Genotype 1 Hepatitis C Virus (HCV) From a Spanish Health Care Perspective

    Nov 1, 2012, 00:00

  • PMS58 Frequency of Administration of Biologics has an Impact on Treatment Decision Making

    Nov 1, 2012, 00:00

  • PSU18 Assessment of the Resource Use and Costs Associated With Parathyroidectomy Surgery for Secondary Hyperparathyroidism in End Stage Renal Disease in the UK

    Nov 1, 2012, 00:00

  • PCV12 Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations- Network Meta-Analyses

    Nov 1, 2012, 00:00

  • PRM169 Internal and External Validity in Economic Modeling- Considerations Based on a Published Example

    Nov 1, 2012, 00:00

  • PMS42 Cost-Utility of Tocilizumab Monotherapy in Methotrexate Intolerant/Contra-Indicated, Moderate/Severe Rheumatoid Arthritis Patients in Portugal

    Nov 1, 2012, 00:00

  • PMD28 Comparing the Cost and Diagnostic Efficiency of Gadoxetic Acid-Enhanced MRI Versus Extracellular Contrast Media-Enhanced MRI and Multidetector Computed Tomography in Patients With Suspected Hepatocellular Carcinoma in Thailand and Kor ...

    Nov 1, 2012, 00:00

  • PHS74 Does Disease Advocacy Impact Priority Setting- Evidence From the Needs and Priorities for Comprehensive Liver Cancer Control in 12 Countries in Europe and Asia-Pacific

    Nov 1, 2012, 00:00

  • PCV52 Cost-Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Portugal

    Nov 1, 2012, 00:00

  • PMS8 The Mortality and Costs from Hip, Vertebral, Wrist and Other Fractures Among Postmenopausal Women in Taiwan

    Nov 1, 2012, 00:00

  • PMS23 Health Related Quality of Life, Measured by the Short Form-36, of Patients with Rheumatoid Arthritis and Ankylosing Spondylitis in an Urban Population of China

    Nov 1, 2012, 00:00

  • PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment

    Nov 1, 2012, 00:00

  • PCV90 A Novel Conceptual Model of Caregiver Burden in Chronic Heart Failure- A Qualitative Study

    Nov 1, 2012, 00:00

  • PMS21 Functional Impairment, Disease Activity, and Duration of Disease Independently Affect the Quality of Life in Patients with Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • Editorial Board

    Nov 1, 2012, 00:00

  • PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Number Needed to Treat (NNT) Analysis

    Nov 1, 2012, 00:00

  • CV2 Age, Dementia, and Evidence-Based Medication Use After Admission for Acute Coronary Syndrome

    Nov 1, 2012, 00:00

  • PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc)- Analysis of Prescription Claims From the Ramq Database

    Nov 1, 2012, 00:00

  • PRS29 Queuing Statistical Model - A New Tool for Preliminary Cost-Effectiveness Assessments

    Nov 1, 2012, 00:00

  • PHP57 Emerging Drug Reimbursement Models- Lessons and Implications from Cancer Drug Access Schemes

    Nov 1, 2012, 00:00

  • PMS35 Cost-Effectiveness of Tocilizumab for the Treatment of Active Rheumatoid Arthritis (RA) Patients With Inadequate Response to Anti-TNF Treatment in Turkey

    Nov 1, 2012, 00:00

  • PCN31 A Cross-Sectional Assessment of the Quality of Life of Cancer Patients and Their Complementary and Alternative Medicines (CAM) Use

    Nov 1, 2012, 00:00

  • PMS9 Budget Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in a Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PDB44 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in Mexico

    Nov 1, 2012, 00:00

  • PCV116 Impact of the Type of Drug Insurance on Cost of Statins and Anti-Depressants

    Nov 1, 2012, 00:00

  • PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C- Submission to the National Institute for Health and Clinical Excellence (NICE)

    Nov 1, 2012, 00:00

  • PCN9 Epidemiology of Venous Thromboembolism Among Cancer Patients in Taiwan

    Nov 1, 2012, 00:00

  • PCN117 Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab- A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone

    Nov 1, 2012, 00:00

  • PSU6 Cost-Effectiveness Analysis of Treatment for Rectal Cancer Following Clinical Complete Response

    Nov 1, 2012, 00:00

  • PUK19 Antimuscarinic Persistence Patterns in Newly Treated Patients With Overactive Bladder (OAB)- Retrospective Comparative Analysis of Fesoterodine, Solifenacin and Tolterodine

    Nov 1, 2012, 00:00

  • PRS32 Allergy Patients Treated With Immunotherapy Experience Increased Quality of Life and Fewer Sick Days After One Year

    Nov 1, 2012, 00:00

  • PHP50 Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions

    Nov 1, 2012, 00:00

  • PCN12 Meta Analytic Comparison of Breast Cancer Risk in Diabetic Women- Important Differences Between Asian and Caucasian Women Suggest Risk Management Startegies

    Nov 1, 2012, 00:00

  • PMD49 Cost-Effectiveness of the TLC-NOSF Dressing in Venous Leg Ulcers

    Nov 1, 2012, 00:00

  • PSY14 Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukaemia- A Probabilistic Decision Model

    Nov 1, 2012, 00:00

  • PIN80 Multivariate Cox Analysis Regarding Treatment Switch on Chronic Hepatitis B (CHB) Disease Management Based on a 2-Year Prospective Study in 5 European (EU) Countries

    Nov 1, 2012, 00:00

  • PCN30 Treatment Patterns and Outcomes of Breast Cancer Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • UT2 Mapping DLQI on EQ-5D in Psoriasis – Transformation of Skin-Specific Health-Related Quality of Life Into Utilities

    Nov 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126 (current)
  • 127
  • 128
  • 129
  • 130
  • »